30035010|t|Lower 123I-FP-CIT binding to the striatal dopamine transporter, but not to the extrastriatal serotonin transporter, in Parkinson's disease compared with dementia with Lewy bodies.
30035010|a|In this retrospective cross-sectional study we compared 123I-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iodophenyl)nortropane (123I-FP-CIT) binding to the striatal dopamine and the extrastriatal serotonin transporter (DAT and SERT, respectively) between Parkinson's disease (PD) and dementia with Lewy bodies (DLB) to gain more insight in the pathophysiology of the two diseases. We compared 123I-FP-CIT single photon emission computed tomography scans of, age-, gender matched patients with cognitive decline in same range of severity with PD (n = 53) or DLB (n = 53) using a regions of interest (ROIs) approach. We derived ROIs anatomically from individual magnetic resonance imaging brain scans. To corroborate the ROI findings, we performed additional whole-brain voxel-based analyses. In both ROI and voxel-based analyses, 123I-FP-CIT binding in PD patients was significantly lower in the bilateral posterior putamen than in DLB patients (left: F(1,103) = 18.363, P < 0.001, omega2  = 0.14; right: F(1,103) = 20.434, P < 0.001, omega2  = 0.15) (Pcorr  < 0.033). Caudate/putamen ratios were also significantly lower in DLB than in PD (U(105) = 724.0, P < 0.001). Extrastriatal SERT binding showed no difference between PD and DLB. These results suggest similar involvement of serotonergic structures in the degenerative process in PD and DLB.
30035010	6	17	123I-FP-CIT	Chemical	MESH:C087552
30035010	42	62	dopamine transporter	Gene	6531
30035010	93	114	serotonin transporter	Gene	6532
30035010	119	138	Parkinson's disease	Disease	MESH:D010300
30035010	153	178	dementia with Lewy bodies	Disease	MESH:D020961
30035010	313	324	123I-FP-CIT	Chemical	MESH:C087552
30035010	350	358	dopamine	Chemical	MESH:D004298
30035010	381	402	serotonin transporter	Gene	6532
30035010	404	407	DAT	Gene	6531
30035010	412	416	SERT	Gene	6532
30035010	440	459	Parkinson's disease	Disease	MESH:D010300
30035010	461	463	PD	Disease	MESH:D010300
30035010	469	494	dementia with Lewy bodies	Disease	MESH:D020961
30035010	496	499	DLB	Disease	MESH:D020961
30035010	578	589	123I-FP-CIT	Chemical	MESH:C087552
30035010	664	672	patients	Species	9606
30035010	678	695	cognitive decline	Disease	MESH:D003072
30035010	727	729	PD	Disease	MESH:D010300
30035010	742	745	DLB	Disease	MESH:D020961
30035010	1014	1025	123I-FP-CIT	Chemical	MESH:C087552
30035010	1037	1039	PD	Disease	MESH:D010300
30035010	1040	1048	patients	Species	9606
30035010	1116	1119	DLB	Disease	MESH:D020961
30035010	1120	1128	patients	Species	9606
30035010	1309	1312	DLB	Disease	MESH:D020961
30035010	1321	1323	PD	Disease	MESH:D010300
30035010	1367	1371	SERT	Gene	6532
30035010	1409	1411	PD	Disease	MESH:D010300
30035010	1416	1419	DLB	Disease	MESH:D020961
30035010	1521	1523	PD	Disease	MESH:D010300
30035010	1528	1531	DLB	Disease	MESH:D020961
30035010	Association	MESH:C087552	MESH:D020961
30035010	Association	MESH:C087552	6531
30035010	Association	MESH:D020961	6531
30035010	Association	MESH:C087552	MESH:D004298
30035010	Association	MESH:C087552	MESH:D003072
30035010	Association	MESH:D010300	6531
30035010	Negative_Correlation	MESH:C087552	MESH:D010300

